Ophthalmic Drug Delivery System Market: How Is Intravitreal Sustained-Release Implant Technology Becoming the Fastest-Growing Posterior Segment Innovation?
Intravitreal sustained-release implant technology — the biodegradable and non-biodegradable devices enabling month-to-year duration anti-VEGF, corticosteroid, and anti-inflammatory delivery directly to the vitreous cavity, eliminating frequent intravitreal injections representing the fastest-growing innovation in the global ophthalmic drug delivery system market — creates the most...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр